Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer

Prof Thomas Powles - Barts Health, London, UK

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer ( Prof Thomas Powles - Barts Health, London, UK )

Metastatic prostate cancer - Interpreting negative trial results

Prof Stephane Oudard and Prof Noel Clarke

Metastatic prostate cancer - Interpreting negative trial results ( Prof Stephane Oudard and Prof Noel Clarke )

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma:...

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )

mRCC: Are we doing all we can to manage adverse events?

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France

mRCC: Are we doing all we can to manage adverse events? ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA

mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )

mRCC: Understanding the patient's perspective

Dr David Cella - Northwestern University, Chicago, USA

mRCC: Understanding the patient's perspective ( Dr David Cella - Northwestern University, Chicago, USA )

mRCC: Panel discussion

Prof Bernard Escudier, Dr Nizar Tannir, Dr David Cella

mRCC: Panel discussion ( Prof Bernard Escudier, Dr Nizar Tannir, Dr David Cella )

mRCC: Closing remarks

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France

mRCC: Closing remarks ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )

ecancermedicalscience editor's choice for January 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for January 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

ecancermedicalscience Special Issue: Fertility sparing

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Special Issue: Fertility sparing ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Advances in haemato-oncology: Expert panel discussion

Prof Jesús San Miguel, Prof Umberto Vitolo, Prof Tim Illidge, Dr Francesc Bosch

Advances in haemato-oncology: Expert panel discussion ( Prof Jesús San Miguel, Prof Umberto Vitolo, Prof Tim Illidge, Dr Francesc Bosch )

Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity...

Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium

Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )

More from ecancer